Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009
21 Outubro 2009 - 8:30AM
PR Newswire (US)
MINNEAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Uroplasty, Inc.
(AMEX:UPI) announced today that it will release financial results
for the second fiscal quarter ended September 30, 2009, at the
market close on Monday, November 2, 2009. The Company will host a
conference call to discuss these results on Monday, November 2,
2009 at 3:30 p.m. Central Time. David Kaysen, President and Chief
Executive Officer, and Medi Jiwani, Vice President, Chief Financial
Officer and Treasurer, will host the call. Individuals wishing to
participate in the conference call should dial 888-561-1721
(domestic) or 480-629-9868 (international). An audio replay will be
available for 30 days following the call at 800-406-7325 (domestic)
or 303-590-3030 (international), with the passcode 4171526 #. About
Uroplasty, Inc. Uroplasty, Inc., headquartered in Minnetonka,
Minnesota, with wholly-owned subsidiaries in The Netherlands and
the United Kingdom, is a medical device company that develops,
manufactures and markets innovative proprietary products for the
treatment of voiding dysfunctions. Our primary focus is on sales
growth in the U.S. market. We offer the Urgent PC® system, which we
believe is the only FDA-approved minimally invasive nerve
stimulation device designed for office-based treatment of urinary
urgency, urinary frequency and urge incontinence - symptoms often
associated with overactive bladder. We also offer Macroplastique®
Implants, an injectable bulking agent for the treatment of adult
female stress urinary incontinence primarily due to intrinsic
sphincter deficiency. Please visit Uroplasty, Inc. at
http://www.uroplasty.com/. For Further Information: Uroplasty, Inc.
David Kaysen, President and CEO, or Medi Jiwani, Vice President,
CFO, and Treasurer, 952.426.6140 EVC Group Doug Sherk/(Investors)
415.896.6820 Chris Gale/Steve DiMattia (Media) 646.201.5431
DATASOURCE: Uroplasty, Inc. CONTACT: David Kaysen, President and
CEO, or Medi Jiwani, Vice President, CFO, and Treasurer, both of
Uroplasty, Inc., +1-952-426-6140; or Investors, Doug Sherk,
+1-415-896-6820, or media, Chris Gale or Steve DiMattia,
+1-646-201-5431, all of EVC Group, for Uroplasty Web Site:
http://www.uroplasty.com/
Copyright
Uroplasty (AMEX:UPI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Uroplasty (AMEX:UPI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Uroplasty Common Stock da American Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Uroplasty,